UBX: Unity Biotechnology Inc. Stocks News on May 15, 2025

Bluebird pleads for deal support; Unity, Mersana lay off staff

UBX

BioPharma Dive

9 days ago

Bluebird pleads for deal support; Unity, Mersana lay off staff

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates

UBX

GlobeNewswire

10 days ago

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting

UBX

GlobeNewswire

14 days ago

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting

UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME

UBX

GlobeNewswire

22 days ago

UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates

UBX

GlobeNewswire

23 days ago

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates

UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study

UBX

Zacks

2 months ago

UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study

Unity reports topline outcomes from trial of diabetic macular oedema therapy

UBX

Clinical Trials Arena

2 months ago

Unity reports topline outcomes from trial of diabetic macular oedema therapy

UBX

MT Newswires

2 months ago

Chardan Cuts Price Target on Unity Biotechnology to $4 From $6, Keeps Buy Rating

UBX

MT Newswires

2 months ago

Sector Update: Health Care

UBX

MT Newswires

2 months ago

Unity Biotechnology Shares Decline After Diabetic Edema Treatment Misses Primary Endpoint

UNITY Biotechnology Shares Drop 33% After Phase 2b Trial Data on UBX1325 in Diabetic Macular Edema

UBX

GuruFocus.com

2 months ago

UNITY Biotechnology Shares Drop 33% After Phase 2b Trial Data on UBX1325 in Diabetic Macular Edema

UBX

MT Newswires

2 months ago

HC Wainwright Adjusts Unity Biotechnology Price Target to $4 From $8, Maintains Buy Rating

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema

UBX

GlobeNewswire

2 months ago

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema

UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025

UBX

GlobeNewswire

2 months ago

UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025

UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors

UBX

GlobeNewswire

2 months ago

UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

UBX

GlobeNewswire

2 months ago

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

UNITY Biotechnology Reports Granting of New Employment Inducement Award

UBX

GlobeNewswire

4 months ago

UNITY Biotechnology Reports Granting of New Employment Inducement Award

UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer

UBX

GlobeNewswire

4 months ago

UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer

We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate

UBX

Simply Wall St.

4 months ago

We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates

UBX

GlobeNewswire

6 months ago

UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024

UBX

GlobeNewswire

8 months ago

UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024

UNITY Biotechnology to Participate in Upcoming Investor Conferences

UBX

GlobeNewswire

9 months ago

UNITY Biotechnology to Participate in Upcoming Investor Conferences

UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know

UBX

Zacks

9 months ago

UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know

UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates

UBX

GlobeNewswire

9 months ago

UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates

UBX

GlobeNewswire

10 months ago

UNITY Biotechnology Reports Granting of New Employment Inducement Award

UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer

UBX

GlobeNewswire

10 months ago

UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer

Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth?

UBX

Simply Wall St.

10 months ago

Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth?

All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy

UBX

Zacks

a year ago

All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy

UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates

UBX

GlobeNewswire

a year ago

UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

UBX

GlobeNewswire

a year ago

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

UBX

MT Newswires

a year ago

Unity Biotechnology Adds More Patients, Extends Length of Trial of Prospective Macular Edema Treatment

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

UBX

GlobeNewswire

a year ago

UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

UBX

GlobeNewswire

a year ago

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

UBX

GlobeNewswire

a year ago

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

ClearSign Technologies Corporation to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference on February 14th-15th

UBX

PR Newswire

a year ago

ClearSign Technologies Corporation to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference on February 14th-15th

UBX

PR Newswire

a year ago

Invesco Closed-End Funds Pay Dividends

Investing in Pyxis Tankers (NASDAQ:PXS) five years ago would have delivered you a 16% gain

UBX

Simply Wall St.

a year ago

Investing in Pyxis Tankers (NASDAQ:PXS) five years ago would have delivered you a 16% gain

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

UBX

GlobeNewswire

a year ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

UBX

Simply Wall St.

a year ago

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

UBX

Business Wire

a year ago

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

NextNav Announces Appointment of John Muleta to Board of Directors

UBX

GlobeNewswire

a year ago

NextNav Announces Appointment of John Muleta to Board of Directors

AST SpaceMobile to Offer $100 Million in Stock After AT&T, Google Deal

UBX

The Wall Street Journal

a year ago

AST SpaceMobile to Offer $100 Million in Stock After AT&T, Google Deal

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

UBX

GlobeNewswire

a year ago

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

Vista Gold Corp. Announces Strategic Update and 2024 Outlook

UBX

Business Wire

a year ago

Vista Gold Corp. Announces Strategic Update and 2024 Outlook

Emcore (EMKR) Is Attractively Priced Despite Fast-paced Momentum

UBX

Zacks

a year ago

Emcore (EMKR) Is Attractively Priced Despite Fast-paced Momentum

UBX

Zacks Small Cap Research

a year ago

TLSA: First Phase II SPMS Patient Dosed

UBX

Business Wire

a year ago

BP Prudhoe Bay Royalty Trust Announces No Unit Payment for the Fourth Quarter of 2023

The 7 Best Monthly Dividend Stocks: 2024 Edition

UBX

InvestorPlace

a year ago

The 7 Best Monthly Dividend Stocks: 2024 Edition

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

UBX

GlobeNewswire

a year ago

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

Flux Power Issues Shareholder Letter and Corporate Update

UBX

Business Wire

a year ago

Flux Power Issues Shareholder Letter and Corporate Update

10 Supplements for Longevity and Antiaging: Expert Recommendations

UBX

Insider Monkey

a year ago

10 Supplements for Longevity and Antiaging: Expert Recommendations

Returns On Capital Are Showing Encouraging Signs At Top Ships (NASDAQ:TOPS)

UBX

Simply Wall St.

a year ago

Returns On Capital Are Showing Encouraging Signs At Top Ships (NASDAQ:TOPS)

American Lithium Files Updated Mineral Resource Technical Report on Falchani Supporting 476% Increase in Measured & Indicated Lithium Resource

UBX

GlobeNewswire

a year ago

American Lithium Files Updated Mineral Resource Technical Report on Falchani Supporting 476% Increase in Measured & Indicated Lithium Resource

Caesarstone (CSTE) to Close Richmond Hill Manufacturing Facility

UBX

Zacks

a year ago

Caesarstone (CSTE) to Close Richmond Hill Manufacturing Facility

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

UBX

GlobeNewswire

a year ago

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

Fathom Realty Welcomes Divine Properties Group, Expanding its Network of Exceptional Agents in California

UBX

PR Newswire

a year ago

Fathom Realty Welcomes Divine Properties Group, Expanding its Network of Exceptional Agents in California

Brilliant Earth Group, Inc. Announces $20 Million Share Repurchase Program

UBX

GlobeNewswire

a year ago

Brilliant Earth Group, Inc. Announces $20 Million Share Repurchase Program

Director Scott Flanders' Strategic Investment in Fathom Holdings Inc

UBX

GuruFocus.com

a year ago

Director Scott Flanders' Strategic Investment in Fathom Holdings Inc

UBX

Business Wire

a year ago

CI&T Recognized in the 2023 Gartner® Magic Quadrant™ for Custom Software Development Services, Worldwide Report

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

UBX

GlobeNewswire

a year ago

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

The Joint Corp.'s (NASDAQ:JYNT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

UBX

Simply Wall St.

a year ago

The Joint Corp.'s (NASDAQ:JYNT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 44% Undervalued

UBX

Simply Wall St.

a year ago

An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 44% Undervalued

Complete Solaria Announces Will Anderson to Remain Interim CEO

UBX

GlobeNewswire

a year ago

Complete Solaria Announces Will Anderson to Remain Interim CEO

DevvStream Announces Participation at Upcoming COP28 Climate Change Conference

UBX

GlobeNewswire

a year ago

DevvStream Announces Participation at Upcoming COP28 Climate Change Conference

Salt Life Continues to Expand Retail Presence

UBX

Business Wire

a year ago

Salt Life Continues to Expand Retail Presence

Decisionpoint Systems, Inc. (AMEX:DPSI) Q3 2023 Earnings Call Transcript

UBX

Insider Monkey

a year ago

Decisionpoint Systems, Inc. (AMEX:DPSI) Q3 2023 Earnings Call Transcript

UBX

PR Newswire

a year ago

Prenetics Announces Third Quarter 2023 Financial Results

UBX

Thomson Reuters StreetEvents

a year ago

Q3 2023 Ci&T Inc Earnings Call

CI&T Inc. (CINT) Q3 Earnings Lag Estimates

UBX

Zacks

a year ago

CI&T Inc. (CINT) Q3 Earnings Lag Estimates

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky

UBX

Simply Wall St.

a year ago

Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky

UBX

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Quest Resource Holding Corp Earnings Call

Complete Solaria Reports Third Quarter 2023 Results

UBX

GlobeNewswire

2 years ago

Complete Solaria Reports Third Quarter 2023 Results

UBX

Business Wire

2 years ago

Danimer Scientific Announces Third Quarter 2023 Results

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

UBX

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates

UBX

GlobeNewswire

2 years ago

UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

UBX

Simply Wall St.

2 years ago

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds

UBX

GlobeNewswire

2 years ago

UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds

Why Earnings Season Could Be Great for Danimer Scientific (DNMR)

UBX

Zacks

2 years ago

Why Earnings Season Could Be Great for Danimer Scientific (DNMR)

UBX

Business Wire

2 years ago

Mogo Reports Results for Q3 2023

UBX

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Franklin Street Properties Corp Earnings Call

UBX

Associated Press Finance

2 years ago

Franklin Street: Q3 Earnings Snapshot

UBX

Associated Press Finance

2 years ago

Western Copper: Q3 Earnings Snapshot

UBX

Associated Press Finance

2 years ago

Upland Software: Q3 Earnings Snapshot

UBX

Business Wire

2 years ago

Latest Unity Biotechnology Inc. (UBX) News on May 15, 2025

Share on Social Networks: